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ABSTRACT 
Simple, sensitive and selective spectrophotometric methods (M1 and M2) for the assay of oseltamivir phosphate 
(OP) through the olefenic double bond are proposed. Method M1 is based on the reaction of potassium 
permanganate to the olefenic double bond in OP and estimating the unreacted permanganate with fast green FCF 
(FGFCF). Method M2 involves the treatment of the olefenic double bond in OP with a Lemieux reagent (mixture of 
KMnO4 and NaIO4) and estimating the aldehyde formed with 3-methyl-2-benzothiazolinone hydrazone (MBTH). 
The color produced in M1 and M2 methods has maximum absorption at 620nm and 654nm respectively. Beer’s law 
obeyed in the concentration range of 4-20µg/ml and 4-12 µg/ml for method M1 and M2 respectively. The precision 
and accuracy of the methods are checked by the reported UV reference method. No interference was observed from 
the usually existing additives in pharmaceutical formulations and the applicability of the methods was examined by 
analyzing NATFLUE capsules containing OP. The both methods are found to be suitable for the determination of 
oseltamivir phosphate. 
KEY WORDS: Assay, FGFCF, Lemieux reagent, MBTH, Beer’s law 
INTRODUCTION 
Oseltamivir phosphate (OP) (Fig.1) is the best known orally active  newest addition to the group of H1N1 
and H5N1 neuraminidase inhibitor and an antiviral drug that slows the spread of influenza (flu) viruses (type A and 
B) between cells in the body by stopping the new virus from chemically cutting ties with its host cell. The drug is 
considered the best treatment for the bird flu disease.  OP is an ethyl ester pro-drug that is rapidly and extensively 
metabolized by esterases in the gastrointestinal tract and liver to its active form, oseltamivir carboxylate(OC). OP is 
a white crystalline powder solid with the chemical name (3R,4R,5S)-4-acetylamino-5-amino-3(1-ethylpropoxy)-1-
cyclohexene-1-carboxylicacid,ethylester, phosphate (1:1) and Its chemical formula is C16H28N2O4.H3PO4 
representing molecular weight of 410.4. 
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Fig.1: Chemical structure of OP 
In literature, OP can be identified by thin layer chromatography, specific optical rotation, infrared 
spectrophotometry and tests characteristic for ortho phosphates1, Determination, by International Pharmacopeia 2, 
can be done by high-performance liquid chromatography 1-2 or by titration with perchloric acid 1. Other analytical 
methods such as UV spectroscopy 3-5, visible spectrophotometric 6-9, colorimetric and LC10, spectrofluorimetric 11, 
HPLC with UV detection 12-19 and mass spectrometry20-23, Micellar electrokinetic chromatography24, capillary 
electrophoresis25 voltammetry26 and potentiometry 27 have been reported for the determination of OP in biological 
fluids and formulations. In the current scenario for the analysis of drugs many oxidants have been applied for 
oxidation. Very few workers have used oxidants to exploit olefenic double bonds. This paper describes analytical 
studies on the role of oxidants in the olefenic double bond in oseltamivir phosphate. It is well known that 
compounds of the R-CH=CH-R1 type undergo oxidation with acid permanganate, directly yielding a mixture of 
carboxylic acids , while in the presence of sodium metaperiodate(Lemieux reagent) they yield a mixture of 
aldehydes. Existing analytical methods reveal that relatively little attention has been paid to develop visible 
spectrophotometric methods. The low λmax value of the colored species in many of the reported methods prompted 
us to explore the possibility of developing new methods with a higher λmax. The efforts of this accord resulted in two 
such procedures, based on the oxidation of OP with KMnO4 and a Lemieux reagent and estimating the unreacted 
permanganate with FGFCF 28(Method M1) or the aldehyde formed with MBTH 
29 (Method M2). The results of these 
methods are statistically validated. These methods can be extended for the routine quality control analysis of 
pharmaceutical products containing OP. 
MATERIALS & METHODS (EXPERIMENTAL) 
Apparatus and chemicals  
A Milton Roy UV/Visible spectrophotometer model-1201 with 10mm matched quartz cells was used for all spectral 
measurements. All the chemicals used were of analytical grade and the solutions wee freshly prepared. Aqueous 
solutions of acid KMnO4 (BDH, 0.0316%, 2.0x10
-3M for M1 or 0.01% 6.32x10
-4M for M2 in 2.0M H2SO4), FGFCF 
solution (Chroma, 0.01%, 1.23x10-4M prepared by dissolving 10mg of fast green FCF in 100ml of 1.0M sulphuric 
acid. 10ml of this solution was further diluted to 100ml with the same strength of acid), Na2SO4 solution 
(BDH,4.2%, 1.0M, prepared by dissolving 4.2g of sodium sulphate in 100ml of distilled water), NaIO4 (Qualigens, 
0.05%, 2.33x10-3M , prepared by dissolving 50mg of sodium meta periodate in 100ml of distilled water and MBTH 
(Fluka, 0.2%, 8.55x10-3M, prepared by dissolving 200mg of MBTH in 100ml of distilled water) were used. 
Preparation of standard drug solution: A 1mg/mL solution was prepared by dissolving 100mg of oseltamavir 
phosphate in 100ml of 20% acetic acid and the stock solution was diluted stepwise with distilled water to obtain 
working standard solutions of 100µg/mL for the both methods (M1 and M2). 
Analytical Procedures: 
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Determination of wavelength maximum (λmax): 
Method M1: 
Method M1: 5.0ml of Standard OP solution was transferred into 25ml calibrated tube. To this 0.5ml of KMnO4 
(2.063x10-3M) solution was added. And the total volume in tube was brought to 10ml with distilled water and set 
aside for 10 min at laboratory temperature. Then 4.0ml each of the FGFCF (1.236x10-4M) solution and sodium 
sulphate (1.0M) solution were added successively After 10 min, the volume was made up to the mark with distilled 
water.  In order to investigate the wavelength maximum, the above colored solution was scanned in the range of 
400-660 nm UV-Visible spectrophotometers against a reagent blank. From the absorption spectra (Fig.2), it was 
concluded that 620nm is the most appropriate wavelength for analyzing OP with suitable sensitivity. 
 
Fig.2: Absorption spectra of OP-KMnO4-FGFCF system 
Method M2: 3.0 ml of Standard OP solution was transferred into 25ml calibrated tube. Then 0.5mL of KMnO4 
(6.32x10-4M) and 1.0mL of NaIO4 (2.33x10
-3M) solutions were added successively and kept in a boiling water bath 
for 10 min. After that 1.0mL of MBTH (8.56x10-3 M) solution was added and heated for another 3 min. The solution 
was cooled to room temperature and the total volume in tube was made up to the mark with distilled water. In order 
to investigate the wavelength maximum, the above colored solution was scanned in the range of 400-660 nm UV-
Visible spectrophotometers against a reagent blank. From the absorption spectra (Fig.3), it was concluded that 
654nm is the most appropriate wavelength for analyzing OP with suitable sensitivity. 
 
Fig.3: Absorption spectra of OP-NaIO4-MBTH  
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Preparation of calibration curve:   
Method M1: Aliquots of Standard OP solution (1.0-5.0mL, 100µg/mL) were transferred into a series of 25mL 
calibrated tubes. To each tube 0.5mL of KMnO4 (2.063x10
-3M) solution was added and the total volume in each 
tube was brought to10mL with distilled water and set aside for 10 min at laboratory temperature. Then 4.0mL each 
of the FGFCF solution and sodium sulphate solution were added successively and set aside for 5 min. for complete 
color development and then diluted to the mark with distilled water.  The absorbance was measured at 620nm 
against a reagent blank prepared simultaneously. The decrease in absorbance corresponding to the drug content was 
obtained by subtracting the absorbance of the blank from that of test solution. The amount of drug was computed 
from its calibration graph (Fig.4). 
 
 
Fig.4: Beer’s law plot of OP-KMnO4-FGFCF system 
Method M2:  
Aliquots of Standard OP solution (1.0-3.0mL, 100µg/mL) were transferred into a series of 25mL calibrated tubes. 
Then 0.5mL of KMnO4 (6.32x10
-4M) and 1.0mL of NaIO4 (2.33x10
-3M) solutions were added successively and kept 
in a boiling water bath for 10 min. After that 1.0mL of MBTH (8.56x10-3 M) solution was added and heated for 
another 3 min. The solution was cooled to room temperature and the total volume in each tube was made up to the 
mark with distilled water. The absorbance was measured after 5 minutes before 60minutes at 654nm against the 
reagent blank prepared similarly. The content of the drug computed from the appropriate calibration graph (Fig.5). 
 
Fig.5: Beer’s law plot of OP-NaIO4-MBTH syste 
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 For pharmaceutical formulations: 
 Preparation of Sample solution 
About 10 capsules were weighed to get the average weight and pulverized and the powder equivalent to 
100mg of OP was weighed, dispersed in 25ml of isopropyl alcohol (IPA), sonicated for 30minutes and filtered 
through whatman filter paper no.41. The filtrate was evaporated and the residue was used for the preparation of 
working sample solution in the same way as under working standard solutions and analyzed under the procedures 
for the bulk samples. The UV method reported earlier using 0.1M NaOH (λmax =216nm) as a solvent was chosen as 
the reference method for ascertaining the accuracy of the proposed methods.    
RESULTS AND DISCUSSION 
The working conditions for the color developments of methods M1 and M2 were established by varying the 
parameters on at a time and keeping the others fixed and observing the effect produced on the absorbance of the 
colored species. The following experiments were conducted for this purposed and the conditions so obtained were 
incorporated into the recommended procedures.  Method M1: 0.4 to 0.6ml of KMnO4 (2.063x10
-3M) and a waiting 
time of 5 to 15 min at room temperature were found to be adequate. A prolonged waiting period or an increase in 
temperature has no additional advantage. Hence 0.5ml of KMnO4 and a waiting time of 10 min were preferred. To 
maintain the linear relationship between the un-reacted KMnO4 and FGFCF, the addition of 4.0ml each of 1.23x10
-
4M and 1.0M sodium sulphate were found to be optimum. The consistency in absorbance after the gradual decrease 
of FGFCF was attained within 5 min and remained stable for further 45 min, and was measured at 620nm. 
Method M2: In the first step, 0.4 to 0.6ml mL of 6.32x10
-4M KMnO4 and 0.5to 1.5mL of (2.33x10
-3M) NaIO4 and 
heating on a boiling water bath for 10to20 min. were found to be necessary to get constant and reproducible 
absorbance values. The values were erratic beyond this range. In the second step, an optimum range of 0.5 to 1.5mL 
of MBTH (8.56x10-3 M) and further heating on a boiling water bath for 2 to5min were found to be adequate to get 
the maximum absorbance. Thus list volumes of KMnO4 (0.5mL, 6.32x10
-4M),   NaIO4(1.0mL,  2.33x10
-3M) and 
MBTH(1.0mL,  8.56x10
-3 M) and heating times of 10 before and 3 min after the addition of MBTH were preferred 
.The color product was stable for one hour and was measured at 654nm. 
Analytical Data 
In order to test whether the colored species formed in the methods adhere to Beer’s law, absorbances at appropriate 
lengths of a set of solutions containing varying amounts of OP and specified amounts of reagents(as given the 
recommended procedures for each method ) were recorded against the corresponding reagent blank. The optical 
characteristics such as Beer’s law limit, Sandell‘s sensitivity, molar absorptivity, percent relative standard deviation, 
(calculated from the six measurements containing 3/4
th
 of the amount of the upper Beer’s law limits), Regression 
characteristics like standard deviation of slope (Sb), standard deviation of intercept (Sa), standard error of estimation 
(Se) and % range of error (0.05 and 0.01 confidence limits) were calculated and the results are summarized in Table-
1.Nat flu capsules were successfully analyzed by the proposed methods. The values obtained by the proposed and 
reference methods for formulations were compared statistically by the t-and F-test and found not to differ 
significantly. As an additional demonstration of accuracy, recovery experiments were performed by adding a fixed 
amount of the drug to the pre-analyzed formulations at three different concentration levels. MS Excel Software-2007 
used for calculations and graphs.  These results are summarized in Table-2. 
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Table - 1 Optical characteristics, precision and accuracy of the proposed methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Y = a + b x, where Y is the absorbance and x is the concentration of OP in µg/ml 
 
 
 
 
 
 
 
 
 
Parameters Method M1 Method M2 
λ max(nm) 620 654 
Beer’s law limit (µg/ml) 4- 20 4-12 
Sandell’s sensitivity 
(µg/cm2/0.001 abs. unit) 0.00195122 0.001327801 
Molar absorptivity 
(Litre/mole/cm) 210330 309082.5 
Regression equation         
(Y) *= a +b x  
  
Intercept (a) -0.007 -0.085 
Slope(b) 0.021 0.040 
%RSD 1.2 1.89 
% Range of errors(95% 
Confidence  limits) 
0.05 significance level 
0.01 significance level 
1.26 1.99 
1.98 3.12 
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Table-2 Analysis of OP in pharmaceutical formulations 
Method *Formulations Labeled 
Amount 
(mg) 
Found by Proposed Methods Found by 
Reference 
Method  ± 
SD 
#% Recovery 
by Proposed 
Method ± SD 
**Amount 
found ± SD 
t F 
M1 
Capsule-1 30 29.59±0.32 
 
1.64 3.94 29.80±0.16 98.62±1.07 
Capsule-2 75 74.44±0.49 0.54 3.35 74.65±0.91 99.26±0.66 
M2 Capsule-1 30 29.79±0.13 0.35 1.55 29.80±0.16 99.29 ± 0.43 
 Capsule-2 75 74.49  ±0.46 0.41 3.8 74.65±0.91 99.30 ± 0.62 
* Capsule- 1 and capsule-2: Natflu capsules of NATCO PHARMA LIMITED, Hyderabad (India)   
**Average ± Standard deviation of six determinations, the t- and f-values refer to comparison of the proposed 
method with UV reference method. Theoretical values at 95% confidence limits t =2.57 and F = 5.05. 
# Recovery of 10mg added to the pre analyzed sample (average of three determinations). 
Reference method (reported UV method) using 0.1M NaOH (λ max=216nm). 
Chemistry of the color species: 
Method M1: This method was based on the reaction of permanganate to the olefenic double bond of cyclo hexene 
moiety in OP (first step) and an estimation of the un-reacted permanganate with FGFCF (second step). The probable 
sequence of reactions are presented in the scheme (Fig.6) 
Method M2: This method involves the treatment of an olefenic double bond with Lemieux reagent (first step) and 
an estimation of the aldehyde formed with MBTH in the presence of oxidants (excess permanganate and periodate 
left after the completion of the reaction) based on the formation of a brilliant blue cationic dye(second step). The 
probable sequence of reactions are presented in the scheme (Fig.7) 
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Fig.6: Probable scheme of the reaction for Method M1 
 
 
Fig.7: Probable Scheme of the reaction for Method M2   
CONCLUSIONS 
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The proposed methods are attractive ones compared to the reported methods since the proposed methods have 
higher λmax. The contaminants do not interfere in the color development. This was further proven by the resulting 
percentage recoveries of the proposed methods. Hence the proposed methods are simple selective and reliable and 
can be used for the assay of OP in bulk samples and pharmaceutical formulations. These methods can be used as 
alternative methods to the reported ones.    
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